NovaLead Pharma topical drug Galnobax for Diabetic Foot Ulcer proceeds for phase 3 trial Farhat Nasim2 Sept 2019 9:45 AM IST"Development of Galnobax and the clinical trials are also supported by Department of Biotechnology under the BIPP program," said Novalead...
Amgen challenges Alexion Pharma blood disorder treatment Soliris in US patent court Medical Dialogues Bureau2 Sept 2019 9:30 AM ISTThe IPR is seeking to invalidate new patents covering the composition of the main ingredient of Soliris, eculizumab, its formulation, and its use to...
4WEB Medical gets USFDA clearance for cervical stand-alone interbody fusion device Farhat Nasim2 Sept 2019 9:14 AM ISTNew Delhi: 4WEB Medical, an orthopaedic device company focused on developing implants utilizing its proprietary Truss Implant Technology, announced...
Kyowa Kirin gets USFDA approval for Nourianz tablets to treat adults with Parkinsons disease Medical Dialogues Bureau2 Sept 2019 9:00 AM ISTNew Delhi: Kyowa Kirin, Inc. recently won the U.S. Food and Drug Administration approval for Nourianz (istradefylline) tablets as an add-on treatment...
Biocon gets 4 observations, Complete Response Letter from USFDA for Insulin Glargine Farhat Nasim1 Sept 2019 10:15 AM ISTThe United Food and Drug Administration (USFDA) has also issued four observations after cGMP inspection of one of Biocon's biologics drug product...
5 pc GDP should act as wake-up call for Government to act more: Kiran Mazumdar Shaw Farhat Nasim1 Sept 2019 10:00 AM ISTKiran Mazumdar Shaw, who heads the south-headquartered Biocon, said the economic growth data clearly suggests a fall in consumption which needs to be...
Sandoz recalls Losartan Potassium, Ezetimibe drug bottles in US over packaging issue Medical Dialogues Bureau1 Sept 2019 9:37 AM ISTNew Delhi: Sandoz Inc. recently announced a voluntary recall and corrective action notice for particular lots of Losartan Potassium and Ezetimibe...
USFDA expands investigation on generic drug impurities in US Medical Dialogues Bureau1 Sept 2019 9:35 AM ISTSince last summer, the USFDA has been conducting a major investigation to address the presence of certain impurities that could cause cancer in ARBs...
AstraZeneca lupus drug Anifrolumab shows encouraging sign in final stage Medical Dialogues Bureau1 Sept 2019 9:30 AM ISTAstraZeneca said Anifrolumab under the TULIP 2 program helped patients with systemic lupus erythematosus, commonly known as SLE.U.S: AstraZeneca Plc...
GSK Pharma sells 60 acres land in Thane to Oberoi Realty for Rs 890 crore Medical Dialogues Bureau31 Aug 2019 12:54 PM ISTMumbai: Glaxo Smith Kline Pharmaceuticals (GSK) has divested around 60 acres of its lands at Thane in favour of Oberoi Realty for nearly Rs 890 crore...
Alkem Labs gets 2 USFDA observations for Daman facility Medical Dialogues Bureau31 Aug 2019 12:32 PM ISTNew Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received two observations from the US health regulator for...
Aurobindo Pharma, Shanghai LongJin sign deal to form JV in China Medical Dialogues Bureau31 Aug 2019 11:17 AM ISTThe joint venture is for development, manufacturing, marketing and sale of pharmaceutical products for China, excluding Taiwan, Hongkong and Macau,...
